Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism MYH2 inhibitors(myosin heavy chain 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cerebral Palsy | Phase 1 | US | 11 Sep 2023 | |
Dystonia | Phase 1 | US | 11 Sep 2023 | |
Multiple Sclerosis | Phase 1 | US | 11 Sep 2023 | |
Muscle Spasticity | Phase 1 | US | 11 Sep 2023 | |
Spastic Paraplegia, Hereditary | Phase 1 | US | 11 Sep 2023 | |
Spinal Cord Injuries | Phase 1 | US | 11 Sep 2023 | |
Stroke | Phase 1 | US | 11 Sep 2023 |